Abstract
Filaggrin may modify the risk for irritant contact dermatitis (ICD) in different ways. In the stratum corneum (SC), which is the principal barrier of the skin, filaggrin is responsible for the structural strength by aggregating the keratin filaments, while its breakdown products contribute to adequate hydration, pH balance, and anti-bacterial defence. Thus, deficiency of filaggrin, whether inherited or acquired, may lead to an impaired epidermal barrier function, facilitating ingress of skin-irritating chemicals and development of ICD. Next to the direct risk-enhancing effect that can be attributed to impaired epidermal barrier, filaggrin may act through atopic dermatitis (AD), which in turn is a major risk factor for ICD.
Recent epidemiological studies provide evidence that filaggrin gene (FLG) mutations confer the risk for chronic ICD. The strongest risk has been found in patients with concomitant AD. FLG mutations in the presence of AD seem also to be a modifier of the severity of the clinical course in ICD, supporting the view that this group represents a special risk population for ICD.
Insight into the role of filaggrin deficiency in the development of ICD may be assisted by more tailored prevention in occupations associated with high prevalence of ICD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith HR, Basketter DA, McFadden JP. Irritant dermatitis, irritancy and its role in allergic contact dermatitis. Clin Exp Dermatol. 2002;27:138–46.
Diepgen TL. Occupational skin disease data in Europe. Int Arch Occup Environ Health. 2003;76:331–8.
Coenraads PJ, Diepgen TL. Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health. 1998;71:7–13.
Dickel H, Bruckner TM, Schmidt A, Diepgen TL. Impact of atopic skin diathesis on occupational skin disease incidence in a working population. J Invest Dermatol. 2003;121:37–40.
de Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H, et al. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case–control study. Br J Dermatol. 2008;159:621–7.
Jakasa I, de Jongh CM, Verberk MM, Bos JD, Kezic S. Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects. Br J Dermatol. 2006;155:104–9.
De Jongh CM, Jakasa I, Verberk MM, Kezic S. Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate. Br J Dermatol. 2005;154:651–7.
McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131(2):280–91.
Scharschmidt TC, Man MQ, Hatano Y, Crumrine D, Gunathilake R, Sundberg JP, et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol. 2009;124:496–506.
Kawasaki H, Nagao K, Kubo A, Hata T, Shimizu A, Mizuno H, et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin null mice. J Allergy Clin Immunol. 2012;129:1538–46.e6.
Angelova-Fischer I, Mannheimer AC, Hinder A, Ruether A, Franke A, Neubert RH, et al. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling. Exp Dermatol. 2011;20:351–6.
Jungersted JM, Scheer H, Mempel M, Baurecht H, Cifuentes L, Høgh JK, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy. 2010;65:911–8.
Küchler S, Henkes D, Eckl KM, Ackermann K, Plendl J, Korting HC, et al. Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim. 2011;39:471–80.
Molin S, Vollmer S, Weiss EH, Ruzicka T, Prinz JC. Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. Br J Dermatol. 2009;161:801–7.
Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365:1315–27.
O’Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40:965–72.
Visser MJ, Landeck L, Campbell LE, McLean WH, Weidinger S, Calkoen F, et al. Impact of loss-of-function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis. Br J Dermatol. 2013;168(2):326–32.
Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John SM. Clinical course of occupational irritant contact eczema of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol. 2012;167:1302–9.
Brown SJ, McLean WH. One remarkable molecule: filaggrin. J Invest Dermatol. 2011;132:751–62.
Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007;120:150–5.
Kezic S, O’Regan GM, Yau N, Sandilands A, Chen H, Campbell LE, et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy. 2011;66:934–40.
Pellerin L, Henry J, Hsu C-Y, Balica S, Jean-Decoster C, Méchin MC, et al. Defects of filaggrin-like proteins in both lesional and non-lesional atopic skin. J Allergy Clin Immunol. 2013;131(4):1094–102.
Janssens M, van Smeden SJ, Gooris GS, Bras W, Portale G, Caspers PJ, et al. Increase in short chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res. 2012;53:2755–66.
Kezic S, O’Regan GM, Lutter R, Jakasa I, Koster ES, Saunders S, et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J Allergy Clin Immunol. 2012;129:1031–9.e1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kezic, S., Visser, M.J. (2014). Irritant Contact Dermatitis. In: Thyssen, J., Maibach, H. (eds) Filaggrin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54379-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-54379-1_24
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54378-4
Online ISBN: 978-3-642-54379-1
eBook Packages: MedicineMedicine (R0)